The Global Lung Injury Market size was valued at $1,579.47 Million in 2021, and is projected to reach $2,417.41 Million by 2028 registering a CAGR of 4% during the forecast period 2022 to 2028.
Lung injury is an inflammatory condition that destroys the endothelial and epithelial barriers in the lungs. ALI and ARDS are life-threatening forms of respiratory failure characterized by extensive bilateral lung damage and severe hypoxemia produced by noncardiogenic pulmonary edema. It is also a leading cause of mortality and morbidity in critically ill patients without evidence of hydrostatic pulmonary edema. Symptoms observed in acute lung injury include severe shortness of breath, low blood pressure, confusion, and extreme fatigue. These types of injuries have significant public health impacts with a high incidence worldwide. In addition, rapid, goal-directed administration of therapy is required to prevent further lung damage.
(Get 15% Discount on Buying this Report)
A full report of Global Lung Injury Market is available at: https://orionmarketreports.com/lung-injury-market/88034/
Market Segments
By Injury Type
- Direct Injury
- Indirect Injury
Key Players
- Bayer AG
- General Electric Company
- Glaxosmithkline Plc,
- Koninklijke Philips N.V.
- Linde Plc.
- Medtronic Plc.
- Ony Biotech Inc
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Scope of the Report
The research study analyzes the global Lung Injury industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Lung Injury Market Report
1. What was the Lung Injury Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Lung Injury Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Lung Injury Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Lung Injury market.
- The market share of the global Lung Injury market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Lung Injury market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Lung Injury market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
